Subtle Medical builds vendor-neutral, AI-powered imaging software designed to operate across existing MRI, PET and CT scanners regardless of manufacturer. Its portfolio includes 11 FDA-cleared software products and its technology is deployed on more than 1,300 scanners globally. The company is developing an AI Imaging Hub intended to help providers manage imaging performance across modalities and scanner fleets. Subtle Medical has been recognized by TIME and by CB Insights on multiple industry lists. Financially, the company has raised a total of $86 million following a $33 million growth financing led by Morgan Stanley Expansion Capital. The company plans to use the new capital to accelerate product development and commercial expansion in the U.S. and international markets.

Total raised

$55M

Funding rounds

3

Latest round

Series C

Latest activity

Jun 2026